Lockdowns, focused protection or rapid tests: the pandemic strategies compared

The Short Version

Three guests of the Lex Fridman Podcast, recorded within months of each other in 2021, argued for three different ways through COVID. Jay Bhattacharya said lockdowns did enormous harm for a virus whose risk rises steeply with age, and that the effort should have gone into focused protection of the old and the chronically ill while the rest of society kept functioning [1]. Michael Mina said the missing tool was information: cheap rapid tests at home that tell people whether they are infectious right now, which the United States lacked because it regulated them as medical devices [2]. Francis Collins, then director of the National Institutes of Health, put vaccination first, with boosters, indoor masking and distancing for the time being, vaccines for poorer countries, and a large push on home tests through the NIH's RADx program [3]. They disagree most about who should be the target of policy, everyone or the vulnerable, and they overlap more than the fight between them suggests on testing, on vaccines for older people and on telling the public the truth [1][2][3].

Table of contents

What They Said

Jay Bhattacharya: protect the vulnerable, open the rest

Jay Bhattacharya is a professor of medicine, health policy and economics at Stanford and a co-author of the Great Barrington Declaration, the October 2020 document that argued against lockdowns and for focused protection of the most vulnerable [1]. He wrote it with Martin Kulldorff of Harvard and Sunetra Gupta of Oxford after they met in Great Barrington, Massachusetts [1]. It is less than a page, written for the public, and he says it restated older pandemic plans rather than anything radical [1]. It rests on two ideas he considers uncontroversial: the steep age gradient in COVID risk, and the devastating harms of lockdowns [1].

The age gradient. Bhattacharya says the best evidence on how deadly COVID is comes from seroprevalence studies, which measure how many people have antibodies and so likely had the infection [1]. He helped run some of the earliest, in Santa Clara County, Los Angeles County and among Major League Baseball employees [1]. In spring 2020 they found 40 to 50 times more infections than reported cases and an infection fatality rate of about 0.2% in community-dwelling populations [1]. He says his Stanford colleague John Ioannidis later found a median worldwide figure of roughly 0.15% to 0.2% in a meta-analysis [1].

The average hides the point he cares about. His rule of thumb, for unvaccinated people before Delta: at age 50 the infection fatality rate is around 0.2%, and it doubles for every seven years older and halves for every seven years younger [1]. A serious chronic condition like diabetes or morbid obesity is roughly like adding seven years [1]. For people over 70 he cites risks around 5% [1]. He says something like 70% to 80% of COVID deaths are in people over 60, and that the flu is more dangerous to children than COVID is [1].

He adds a practical consequence of the antibody studies: with that many infections already, suppression to zero was never realistic [1]. He expects COVID to become endemic, with reinfections generally milder [1].

The harms. The second pillar is a list. He cites UN warnings of mass hunger, with hundreds of thousands of children in South Asia dying of starvation; disrupted tuberculosis treatment, vaccination and malaria programs; and India's lockdown, which forced some 10 million migrant workers to travel home, with about a thousand dying on the way [1]. In rich countries he cites a July 2020 study in which one in four young adults seriously considered suicide, school closures that hit poor and middle-class children hardest, skipped cancer screenings, people dying at home of heart attacks, rising overdoses, and a 3% drop in labor force participation, much of it women staying home with children [1].

He recalls a reporter warning him early on that mentioning economic harms would get him canceled [1]. His answer is that the money in question "is actually lives of poor people" [1]. "When you throw 100 million people around the world into poverty, you're going to see enormous harm to their health, enormous increases in their mortality," he says, and it is not immoral to worry about that [1]. Lockdowns, he says, protected "the laptop class" while essential workers kept working and getting sick [1].

Lex Fridman frames the episode the same way in his introduction: "The landscape of suffering is vast and must be fully considered in calculating the response to the pandemic" [1].

What focused protection means. It means protecting those at highest risk while letting the rest of society function, and it has to be worked out locally, since it depends on living arrangements and resources [1]. He argues nursing homes should have been the key concern from the start, rather than hospital bed capacity; the focus on beds led some Northeast states to send COVID patients back to nursing homes [1]. Protecting the vulnerable would also have eased hospital pressure [1].

His examples are concrete. Organize grocery delivery for older people, as was done for the laptop class [1]. Have public health offer a hotel room so a young person who may have been exposed can isolate away from a grandparent; in the transcript the grandson calls after a party, the grandmother calls public health, and he gets the room for a couple of days until he tests negative [1]. Businesses, schools and places of worship stay open, though he expects people would voluntarily go to fewer big gatherings [1].

He rejects the label that stuck to the plan. "The goal isn't to let the virus rip. The goal is to protect the vulnerable," he says, and he notes that the words let it rip do not appear in the declaration [1]. What he wanted, he says, was "a discussion by local public health about better methods, better policies to protect the vulnerable" [1].

The vaccine as focused protection. Bhattacharya calls the vaccines a godsend for older people, reducing their risk of death roughly tenfold [1]. "It transforms the problem of focus protection from something that's quite challenging, possible, I believe, quite challenging, into something that's much, much more manageable," he says [1]. He names two things he got wrong: in March 2020 he assumed a vaccine would take a decade or more, and in January 2021 he thought the vaccines would stop infection [1]. Data from Israel showed otherwise: protection against infection starts around 60% to 70% and wanes within months, though protection against severe disease holds up well [1].

Fear and trust. He says "fear should never be used as a tactic to manipulate human behavior by public health" [1]. Public health's job is to manage fear with accurate risk information and to level with people when things are unknown [1]. In the transcript he says there has been "a deliberate policy to stoke the fear," and that young people gave up regular life because they feared COVID more than they ought and feared harming the vulnerable people in their lives: "You put those two together and you get this powerful demand for lockdowns" [1].

Michael Mina: make infectiousness visible

Michael Mina is a Harvard immunologist, epidemiologist and physician, and his case is the one he had been making since early 2020: cheap, paper-strip rapid antigen tests used at home are among the most powerful and obvious tools against COVID-19 [2].

The right question. Mina calls the tests "infectiousness indicators" [2]. Swab the front of the nose, mix it in a tube, drop it on a strip and read one or two lines after about 10 minutes [2]. PCR is far more analytically sensitive and can detect one molecule instead of 100,000, but he says that extra sensitivity has been a net negative for public health [2]. The virus can grow from zero to a billion in a day, so a test that catches high viral loads at once beats one that catches tiny amounts days later, especially when a PCR round trip can take four days [2].

Sensitivity, he argues, only means something when you ask what the test is sensitive to [2]. Against infectious people, rapid tests are about 97 percent sensitive; against potential super-spreaders, essentially 100 percent [2]. People are infectious for roughly three to seven days but can stay PCR-positive for 30 to 70 days, so isolating people or blocking travel on a lingering PCR positive is bad public health practice and a huge disincentive to test [2].

Why the US lacked them. The core obstacle, Mina explains, is that rapid tests are evaluated as medical devices against PCR as the gold standard [2]. If you are infectious for only about 20 percent of the time you are PCR-positive, a perfect contagiousness test would show only around 20 percent sensitivity against PCR, far below the 80 percent the FDA asks for [2]. He does not think the FDA is acting in bad faith; it has one job, authorizing medical claims, and there is no other route [2]. "We have defunded and devalued public health for so long that we literally don't have a language for it" [2].

He points to an inconsistency: pooled PCR testing of millions of schoolchildren needs no authorization, while a single rapid test used for the same purpose does, because a result that changes one person's behavior counts as a medical device [2].

His fix is one executive action stating that "any tools used for public health testing during this public health emergency will be designated as public health tools," which would let the CDC evaluate them on the right metrics [2]. Tests that had performed well in Europe for months could then be certified quickly [2]. In Germany, with 60 to 70 authorized makers, tests sell for about 80 cents; manufacturing can cost 50 cents or less [2].

Why doctors resisted. Mina, a physician himself, says the biggest barrier was putting clinicians and clinical labs in charge of pandemic testing decisions [2]. A doctor cares about the one patient in front of them and wants the most sensitive test [2]. Public health has to account for everyone not being tested and every day between tests, so accessibility, frequency and speed matter most [2]. He compares physicians to a TSA agent scanning one bag perfectly who is not responsible for the people walking around security [2].

The program. He does not propose testing everyone every day. Every household keeps a box of tests in the cupboard [2]. When wastewater monitoring or clinics show the virus rising, officials text households to test weekly; where outbreaks appear in pockets, residents of that zip code test every day or two for a week, then stop [2]. Tests could also shorten isolation, letting people isolate only as long as they are actually infectious instead of an arbitrary 10 days [2].

Privacy. Mina agrees with Lex that everyone has a right to know their own status, that reporting to public health agencies should not be a barrier to testing, and that people should be able to opt out and keep results only on their phone [2].

His deepest point. COVID, he says, is an information problem [2]. Schools closed and classrooms were quarantined not because everyone was positive but because nobody knew who was: "That's not a biological problem that's an information problem" [2]. If everyone "glowed green when they were infectious," society would never have needed to close [2].

On vaccines. Mina stresses that the vaccines still largely keep people out of the hospital, but do not stop transmission well, so herd immunity will not come from them alone [2]. He dislikes the rule of vaccinate or test, because vaccinated people can still transmit; it should be vaccinate and test [2]. He rejects the phrase about a pandemic of the unvaccinated, and says the unvaccinated are often simply scared and unsure whom to trust [2].

Francis Collins: vaccinate, boost, mask for now, and scale the tests

Francis Collins was director of the National Institutes of Health under Presidents Obama, Trump and Biden, and the conversation was recorded shortly after he announced he would step down [3].

His plan. Collins's full solution, as he lays it out: vaccinate the 64 million hesitant US adults, vaccinate kids, boost those due, keep masking and distancing indoors for now, and speed vaccine access in low- and middle-income countries, where new variants are likely to arise [3]. He worries about variants, noting how Delta swept the world within months [3]. He says vaccines have held up well against variants because the immune system produces a diversity of antibodies, especially after boosters, and that mRNA vaccines could be quickly redesigned if needed [3].

His reading of the risk. Collins cites estimates that at least 100,000 of 700,000 US deaths were unnecessary deaths of unvaccinated people [3]. He points out that the average ICU patient with COVID was under 50, that a very fit professional wrestler nearly died, and that about 700 children had died, many without underlying conditions [3].

On tests. Lex tells him he is surprised and frustrated that rapid at-home testing was not a big part of the solution from the very beginning, and Collins shares his enthusiasm [3]. He describes how NIH received a billion dollars to create the RADx program, which worked like a venture capital firm with what he calls a shark tank of experts in business, engineering, supply chains and manufacturing [3]. He says most of the home tests on pharmacy shelves came out of that program [3]. "I wish we had done it faster, but it was an amazingly speedy effort," he says [3]. He expected about 410 million tests for December, and says that with one or two more platforms approved, "we could be in the half a billion tests a month, which is really getting where we need to be" [3]. NIH helped companies get FDA emergency use authorization and was acting as the FDA's validation lab [3]. It was also running community-wide free testing trials measured by wastewater [3].

On trust. Collins believes the best way to build trust is to tell the truth [3]. He says he can fully empathize with hesitant people bombarded by conflicting information, and has no sympathy for those who knowingly spread false information [3]. On masks, he says early advice reflected a shortage needed for hospitals and a lack of knowledge about asymptomatic spread [3].

The email. The Bhattacharya conversation supplies Collins's view of focused protection. In an October 2020 email obtained through a freedom of information request, Collins called Bhattacharya and his co-authors "three fringe epidemiologists" and asked Anthony Fauci whether a "quick and devastating published take down" of the declaration was underway [1]. Lex says Collins later doubled down on the word fringe [1].

Where They Agree, and Where They Don't

Lockdown or focused protection. This is the sharpest split. Bhattacharya says the lockdown was the policy put forward by Collins, Fauci and a relatively small number of scientists advising governments, and that the declaration criticized that one policy [1]. Collins's email treated the alternative as fringe [1]. Bhattacharya's view of why: "I think he was looking at this, a great barrington declaration as a political problem to be solved as opposed to a serious alternative approach to the epidemic" [1]. He traces it to a conflict of roles, since the NIH exists to fund science, not set public health policy [1].

Who is at risk. Bhattacharya builds everything on the age gradient and says the data did not support parents' fears for their children [1]. Collins stresses the cases the gradient can make people forget: ICU patients who averaged under 50, and about 700 children who died [3]. Each number supports a different target for policy. Bhattacharya's leads to shielding the old; Collins's leads to vaccinating everyone, children included [1][3].

Stopping spread or reducing harm. Bhattacharya says the underlying error is trying to stop the spread of a virus that is here to stay, rather than reducing harm [1]. Mina wants to cut transmission, but with information instead of closure, and only enough to get R below one [2]. Collins wants masking and distancing indoors kept for now [3].

Tests: everyone is for them, and the numbers differ. Lex says to Collins that nobody is against testing [3]. Mina welcomes the Biden plan's 280 million tests but warns that it is less than one test per American per year [2]. Collins speaks of 410 million in a single month and half a billion a month as where the country needs to be [3]. Bhattacharya's hotel-room example depends on a test turning negative [1].

How tests should be approved. Mina wants rapid tests taken out of the FDA's medical device lane and judged by the CDC as public health tools [2]. Collins describes NIH helping companies through FDA emergency use authorization and serving as the FDA's validation lab [3]. Both describe the same bottleneck from different sides of it.

Vaccines. All three praise them. Bhattacharya calls them a godsend for older people [1]; Mina says they largely keep people out of the hospital [2]; Collins calls them an amazing scientific achievement [3]. Bhattacharya and Mina both say they do not stop transmission well [1][2]. They part on what follows. Bhattacharya treats the vaccine as focused protection for the old and objects to demonizing hesitant people and denying that recovery provides strong immunity [1]. Mina says vaccinate and test [2]. Collins wants every hesitant adult and children vaccinated [3].

The unvaccinated. Mina rejects blaming them and worries that a have-to framing could politicize testing, one of the few bipartisan tools [2]. Bhattacharya says people who recovered should be allowed to work instead of being ostracized [1]. Collins empathizes with the hesitant and counts the unnecessary deaths [3].

Institutions. Bhattacharya and Mina both locate the failure in who was put in charge. For Bhattacharya it was a research funder shaping pandemic policy [1]. For Mina it was clinicians and a medical-device regulator deciding a public health question [2]. Collins defends NIH's record firmly and says changing guidance reflected changing science [3].

Honesty with the public. Here they converge in words. Bhattacharya: tell people the risks and do not treat them like children [1]. Collins: tell the truth [3]. Mina: people have a right to know their own status [2]. Lex presses Collins that leaders should also admit errors with humility; Collins suspects more humility would not stop people looking for a target to blame [3].

How it ends. Bhattacharya expects an endemic virus with milder reinfections [1]. Mina expects people to grow out of it through repeated exposures and vaccinations, as babies grow out of their vulnerable period, and is careful not to encourage anyone to get infected [2]. Collins keeps his eye on the next variant [3].

Why It Works

Why age-targeting can work. If risk doubles every seven years of age, most of the deaths sit in a minority of the population, and Bhattacharya says 70% to 80% of deaths are in people over 60 [1]. Protecting that group addresses most of the mortality, and he argues it would also have eased the pressure on hospitals [1]. A tenfold cut in older people's risk of death from vaccination makes the same strategy much easier [1].

Why the denominator matters. Bhattacharya recalls the 2009 H1N1 flu, where early fatality estimates of 3% to 4% fell to about 0.02% once antibody studies showed how many had been infected [1]. That is why he ran seroprevalence studies quickly in 2020 [1].

Why lockdowns cost lives too. His mechanism is poverty and neglect of other health priorities: hunger, interrupted treatment programs, missed screenings, isolation [1]. One of the voices in his conversation says that we are not meant to live apart from one another [1].

Why a less sensitive test can be the better tool. Mina's argument rests on timing. The virus rises from nothing to a huge load within a day, the infectious window is three to seven days, and PCR stays positive for 30 to 70 days [2]. A fast test that reads high viral load catches people when they can spread it and releases them when they cannot [2].

Why imperfect testing still suppresses outbreaks. The goal is only to get R below one [2]. Mina's arithmetic: if 100 infected people go on to infect 95 instead of 140, after about four weeks there are around 20 cases instead of about 600 [2].

Why information replaces closure. Mina says schools closed because nobody knew who was infectious [2]. Both he and Lex describe how testing before gatherings removes anxiety and makes people kinder and more relaxed [2].

Why vaccines held against variants. Collins says the immune system produces a diversity of antibodies, especially after boosters [3]. Mina describes the other side of it: ongoing spread among the vaccinated gives the virus a boot camp to evolve around vaccine antibodies [2].

Why RADx moved quickly. Collins credits a model that threw test developers into a shark tank of people who understood supply chains and manufacturing, and then helped them through authorization [3].

Where It Applies, and Where It Doesn't

Bhattacharya's numbers have a date and a population. His rule of thumb is for unvaccinated people before Delta [1]. His infection fatality figure is for community-dwelling populations [1]. He acknowledges the studies drew heavy criticism [1].

Focused protection is hard, by his own account. He admits it would be challenging and imperfect in a mixed society, and notes that people got sick under lockdowns anyway [1]. It has to be designed locally [1]. The summary of his conversation calls it a thoughtful, if clearly one-sided, look at the debate [1].

The vulnerable group changes with the disease. Bhattacharya says the principle stays the same in a future pandemic even if the group at risk is different; with polio, children were most at risk and closing schools made sense [1].

Rapid tests answer one question. Mina's case is about contagiousness and public health [2]. He grants that a doctor treating one patient wants the most sensitive test [2].

Lockdowns needed a technology. One of the voices in the Bhattacharya conversation says, "if we didn't have zoom, we wouldn't have lockdowns," and that this is a reason there was no lockdown in 2009 [1].

Supply sets the limit on any testing plan. Mina's warning about 280 million tests and Collins's hope for half a billion a month are both statements about how many tests exist [2][3].

These are conversations from 2021. Mina spoke in the fall, Bhattacharya late in the year, Collins as he prepared to leave office [1][2][3]. Their forecasts and figures belong to that moment.

None of this is personal medical advice. Decisions about vaccination, testing and isolation for a particular person belong with that person's doctor and current public health guidance.

What To Do With It

1. In the next outbreak, find the denominator first. Bhattacharya's lesson from H1N1 and from spring 2020 is to run antibody studies early, so the true fatality rate is known [1].

2. Find out who is at risk, and aim there. For COVID it was the old and the chronically ill; for polio it was children [1]. The measures follow from the answer.

3. Start with nursing homes, not bed counts. Bhattacharya says the early focus on hospital capacity sent infected patients back into the places with the most vulnerable people [1].

4. Give the vulnerable practical help. Grocery delivery for older people, and a hotel room for a household member who may have been exposed [1].

5. Keep a box of rapid tests at home and use them on a signal. Mina's program asks households to test when wastewater or clinics show the virus rising, and to stop when it falls [2].

6. Ask of any test: sensitive to what? For deciding whether to see people today, Mina says the fast test that reads infectiousness is the right one [2].

7. Test before gatherings, and to shorten isolation. Mina describes both uses [2]; Bhattacharya's grandson waits for a negative before going home [1].

8. Press for a public health pathway for tests. Mina's call to action is to ask leaders to designate these as public health tools, since "testing is a public health good" [2].

9. Protect privacy so people keep testing. Mina says reporting should not be a barrier and people should be able to keep results on their own phone [2].

10. Tell people the real risks. Bhattacharya says not to treat people like children and never to use fear as a tactic [1]. Collins says the way to build trust is to tell the truth [3].

Sources

1. Jay Bhattacharya on the Case Against Lockdowns, Focused Protection and Scientific Humility · Lex Fridman Podcast
2. Michael Mina on Rapid At-Home COVID Testing as a Public Health Tool · Lex Fridman Podcast
3. Francis Collins on Lab-Leak, Gain-of-Function, Vaccines, Trust in Science and Faith · Lex Fridman Podcast